Stock Groups

U.S. Senator Sanders will oppose Biden nominee for FDA commissioner -statement -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: Robert Califf, Food and Drug Administration commissioner, speaks at his hearing in the Senate Health, Education, Labor and Pensions Committee, Capitol Hill, Washington, November 17, 2015. REUTERS/Gary Cameron/Fil

WASHINGTON, (Reuters) – U.S. On Tuesday, Senator Bernie Sanders declared that he would not support Robert Califf as President Joe Biden’s nominee to be Food and Drug Administration Commissioner. This is due to his close ties with the pharmaceutical sector.

“The COVID-19 outbreak has clearly shown the difference between profiting from pharmaceuticals and protecting the health of our citizens,” Sanders said. Sanders released a statement saying that Dr. Califf, the FDA’s leader in this moment of crisis is no longer the one Americans want. He will not be the nominee.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]